Literature DB >> 22132361

Sertraline and low-dose doxepin treatment in severe agitated-anxious depression with significant gastrointestinal complaints:two case reports.

Lisa Maclean1, Brian K Ahmedani.   

Abstract

Entities:  

Year:  2011        PMID： 22132361      PMCID： PMC3219524          DOI： 10.4088/pcc.11l01152

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  6 in total

Review 1.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials.

Authors:  R B Lydiard; S A Falsetti
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

2.  Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression.

Authors:  Paolo Olgiati; Alessandro Serretti; Cristina Colombo
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

3.  Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

Authors:  J L Jackson; P G O'Malley; G Tomkins; E Balden; J Santoro; K Kroenke
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

4.  State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting.

Authors:  G Addolorato; A Mirijello; C D'Angelo; L Leggio; A Ferrulli; L Abenavoli; L Vonghia; S Cardone; V Leso; A Cossari; E Capristo; G Gasbarrini
Journal:  Int J Clin Pract       Date:  2008-04-18       Impact factor: 2.503

Review 5.  Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment.

Authors:  Carol S North; Barry A Hong; David H Alpers
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

6.  The anti-anxiety and anti-agitation effects of paroxetine in depressed patients.

Authors:  G C Dunbar; D L Fuell
Journal:  Int Clin Psychopharmacol       Date:  1992-06       Impact factor: 1.659
  6 in total
  1 in total

Review 1.  Major depressive disorder: mechanism-based prescribing for personalized medicine.

Authors:  Philip F Saltiel; Daniel I Silvershein
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-31       Impact factor: 2.570
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.